NR4A1 and breast cancer: Gonzalez-Angulo et al. [41] showed that a high expression of RAB25 was associated with higher recurrence-free survival in breast cancer patients, but they observed that RAB25 loss its predictive value when they analyzed hormone receptor-positive tumors only.